Summary
The symptomatic therapy of hereditary angioneurotic edema with tranexamic acid and suramin in two patients is reported. The first patient responded well to tranexamic acid (Cyclocapron®) but not to suramin. In the second patient, attacks of edema could apparently be better prevented with suramin.
Zusammenfassung
Es wird über die symptomatische Therapie des hereditären angioneurotischen Ödems mit Tranexamsäure und Suramin bei zwei Patienten berichtet. Während der erste Patient gut auf eine Therapie mit Tranexamsäure (Cyclocapron®), nicht jedoch auf Suramin ansprach, ließen sich beim zweiten Patienten die Ödemanfälle mit Suramin unterbinden.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ablondi, F.B., Hagan, J.J., Philips, M., De Renzo, E.C.: Inhibition of plasmin, trypsin, and the streptokinase-activated fibrinolytic system by ε-aminocaproic acid. Arch. Biochem. Biophys.82, 153 (1959).
Alkaersig, N., Fletcher, A.P., Sherry, S.: ε-aminocaproic acid: An inhibitor of plasminogen activation. J. biol. Chem.234, 832 (1959).
Austen, K.F.: Inborn and acquired abnormalities of the complement system of man. Hopkins med. J.128, 75 (1971).
Bruhn, H.D., Mueller, L., Duckert, F.: Quantitative determination of plasminogen. A caseinolytic method. Thrombos. Diathes. haemorrh. (Stuttg.)23, 191 (1970).
Champion, R.H., Lachmann, P.J.: Hereditary angio-oedema treated with ε-aminocaproic acid. Brit. J. Derm.81, 763 (1969).
Donaldson, V.H., Evans, R.R.: Biochemical abnormality in hereditary angioneurotic edema: Absence of serum inhibitor of C′1 esterase. Amer. J. Med.35, 37 (1963).
Fong, J.S.C., Good, R.A.: Suramin—a potent reversible and competitive inhibitor of complement systems. Clin. exp. Immunol.10, 127 (1972).
Frank, M.M., Sergent, J.S., Kane, M.A., Alling, D.W.: Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. New Engl. J. Med.286, 808 (1972).
Juhlin, L., Michaelsson, G.: Vascular reactions in hereditary angioneurotic edema. Acta derm.-venereol (Stockh.)49, 20 (1969).
Kueppers, F., Berendes, U., Schöpf, E.: Inherited high serum levels of a functionally deficient complement esterase inhibitor associated with hereditary angioedema. Hum. Genet.15, 119 (1972).
Laurell, A.B., Martensson, U.: C1 inactivator protein complexed with albumin in plasma from a patient with angioneurotic edema. Europ. J. Immunol.1, 146 (1971).
Lundh, B., Laurell, A.B., Wetterquist, H., White, T.: A case of hereditary angioneurotic oedema successfully treated with ε-aminocaproic acid. Studies on C′1 esterase inhibitor, C′1 activation, plasminogen level and histamine metabolism. Clin. exp. Immunol.3, 733 (1968).
Mancini, G., Carbonara, O.A., Heremans, J.F.: Immunochemical quantitation of antigen by single radial immunodiffusion. Immunochemistry2, 235 (1965).
Nilsson, J.M., Andersson, L., Bjorkman, S.E.: Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 years' clinical experience. Acta med. scand., Suppl.448, 1 (1966).
Nyman, D.: The preparation of an artificial reagent for the onestage factor VIII assay. Thrombos. Diathes. haemorrh. (Stuttg.)23, 306 (1970).
Ratnoff, O.D., Pensky, J., Ogston, D.: Inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C′1r subcomponent of the first component of complement by serum C′1 esterase inhibitor. J. exp. Med.129, 315 (1969).
Rosen, F.S., Charche, P., Pensky, J., Donaldson, V.H.: Hereditary angioneurotic edema: two genetic variants. Science148, 952 (1965).
Rosen, F.S., Alper, C.A., Pensky, J., Klemperer, M.R., Donaldson, V.H.: Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. J. clin. Invest.50, 2143 (1971).
Schreiber, A.D., Kaplan, A.P., Austen, K.F.: The common activation and regulation of the coagulation, fibrinolytic, and kinin-generating pathways in human plasma. J. clin. Invest.51, 87a (1972).
Schumann, G., Mueller, H.-L.: Eine einfache Methode zur serienmäßigen Bestimmung der Komplement-Aktivität im Serum. Z. Immun.-Forsch.141, 201 (1971).
Sheffer, A.L., Austen, K.F., Rosen, F.S.: Treatment of hereditary angioedema with trans-AMCHA. J. Allergy49, 133 (1972).
Author information
Authors and Affiliations
Additional information
This work was supported in part by Schweiz. Nationalfonds zur Förderung der wissenschaftlichen Forschung, Credit No 3.479.70.
Rights and permissions
About this article
Cite this article
Brackertz, D., Kueppers, F. Possible therapy in hereditary angioneurotic edema (HAE). Klin Wochenschr 51, 620–622 (1973). https://doi.org/10.1007/BF01468576
Issue Date:
DOI: https://doi.org/10.1007/BF01468576